Companies: 10,795·Total market cap: $144.5T
Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd.

ENLVNASDAQHealthcare● Active
$0.74
+$0.02(+3.18%)
Market Cap$17908932
P/E Ratio—
52W High$2.1
52W Low$0.66
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Enlivex Therapeutics Ltd. (ENLV) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001596812 · ENLV · NASDAQ · as of Jun 10, 2026

Filing snapshot

395
Total Filings
6-K
Latest Form
2026-05-28
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001596812 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-25
Fiscal Year End
Mar 25, 2026
Accession No.
0001213900-26-033857
Primary Document
ea0282960-20f_enlivex.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001596812 · Accession 0001213900-26-033857

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-15
View
424B3424B3
PROSPECTUS
2026-05-01
View
EFFECTEFFECT
EFFECT
2026-04-30
View
CORRESPCORRESP
CORRESP
2026-04-28
View
UPLOADUPLOAD
UPLOAD
2026-04-27
View
F-3F-3
REGISTRATION STATEMENT
2026-04-21
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-21
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
CURRENT REPORT
2026-03-26
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-03-25
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-25
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-24
View
Showing 1–15 of 395 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001596812  |  Exchange: NASDAQ · Healthcare

Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has submitted 395 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001596812, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Enlivex Therapeutics Ltd.'s most comprehensive regulatory disclosure. The most recent Enlivex Therapeutics Ltd. 10-K was filed on 2026-03-25 for fiscal year ending 2026. Historical ENLV 10-K annual reports are available from 2014 through 2026.

Investors researching Enlivex Therapeutics Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
NRXS SEC Filings →LSTA SEC Filings →XCUR SEC Filings →NRSN SEC Filings →PASG SEC Filings →GDTC SEC Filings →NCNA SEC Filings →CVKD SEC Filings →
→ ENLV Financials→ ENLV Earnings→ ENLV Insider Trades

Frequently Asked Questions

ENLV SEC Filings · 8 questions

Enlivex Therapeutics Ltd. (ENLV) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 395 filings and access original documents at no cost. Enlivex Therapeutics Ltd.'s CIK is 0001596812.

ENLV SEC filingsEnlivex Therapeutics Ltd. SEC documentsfind ENLV 10-K